The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Invasive Fungal Disease (IFD) Drugs Market Research Report 2024
Synopsis
Invasive Fungal Disease (IFD) refers to an infectious disease in which fungi invade the human body, grow and multiply in tissues, organs or blood, and cause inflammatory reactions and tissue damage. The main pathogenic bacteria are Aspergillus and Candida.The mainstream treatment methods for IFD are drug treatment and prevention. The mainstream drugs are triazole drugs, including posaconazole, itraconazole, fluconazole and voriconazole.
The global Invasive Fungal Disease (IFD) Drugs market was valued at US$ 2573 million in 2023 and is anticipated to reach US$ 3461 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Invasive Fungal Disease (IFD) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Invasive Fungal Disease (IFD) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Invasive Fungal Disease (IFD) Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Invasive Fungal Disease (IFD) Drugs include Pfizer, Merck, Gilead Sciences, Xellia, Lupin Limited, Abbott, Creogenic Pharma, Taj Pharmaceuticals, Astellas Pharma, Jiangsu Aosaikang Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Invasive Fungal Disease (IFD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Fungal Disease (IFD) Drugs.
The Invasive Fungal Disease (IFD) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Invasive Fungal Disease (IFD) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Invasive Fungal Disease (IFD) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Merck
Gilead Sciences
Xellia
Lupin Limited
Abbott
Creogenic Pharma
Taj Pharmaceuticals
Astellas Pharma
Jiangsu Aosaikang Pharmaceutical
Segment by Type
Oral Medicine
Injectable Medicine
Segment by Application
Hospital
Drugstore
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Invasive Fungal Disease (IFD) Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Invasive Fungal Disease (IFD) refers to an infectious disease in which fungi invade the human body, grow and multiply in tissues, organs or blood, and cause inflammatory reactions and tissue damage. The main pathogenic bacteria are Aspergillus and Candida.The mainstream treatment methods for IFD are drug treatment and prevention. The mainstream drugs are triazole drugs, including posaconazole, itraconazole, fluconazole and voriconazole.
The global Invasive Fungal Disease (IFD) Drugs market was valued at US$ 2573 million in 2023 and is anticipated to reach US$ 3461 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Invasive Fungal Disease (IFD) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Invasive Fungal Disease (IFD) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Invasive Fungal Disease (IFD) Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Invasive Fungal Disease (IFD) Drugs include Pfizer, Merck, Gilead Sciences, Xellia, Lupin Limited, Abbott, Creogenic Pharma, Taj Pharmaceuticals, Astellas Pharma, Jiangsu Aosaikang Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Invasive Fungal Disease (IFD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Fungal Disease (IFD) Drugs.
The Invasive Fungal Disease (IFD) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Invasive Fungal Disease (IFD) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Invasive Fungal Disease (IFD) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Merck
Gilead Sciences
Xellia
Lupin Limited
Abbott
Creogenic Pharma
Taj Pharmaceuticals
Astellas Pharma
Jiangsu Aosaikang Pharmaceutical
Segment by Type
Oral Medicine
Injectable Medicine
Segment by Application
Hospital
Drugstore
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Invasive Fungal Disease (IFD) Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Medicine
1.2.3 Injectable Medicine
1.3 Market by Application
1.3.1 Global Invasive Fungal Disease (IFD) Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugstore
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Invasive Fungal Disease (IFD) Drugs Market Perspective (2019-2030)
2.2 Global Invasive Fungal Disease (IFD) Drugs Growth Trends by Region
2.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Invasive Fungal Disease (IFD) Drugs Historic Market Size by Region (2019-2024)
2.2.3 Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Region (2025-2030)
2.3 Invasive Fungal Disease (IFD) Drugs Market Dynamics
2.3.1 Invasive Fungal Disease (IFD) Drugs Industry Trends
2.3.2 Invasive Fungal Disease (IFD) Drugs Market Drivers
2.3.3 Invasive Fungal Disease (IFD) Drugs Market Challenges
2.3.4 Invasive Fungal Disease (IFD) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Invasive Fungal Disease (IFD) Drugs Players by Revenue
3.1.1 Global Top Invasive Fungal Disease (IFD) Drugs Players by Revenue (2019-2024)
3.1.2 Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Invasive Fungal Disease (IFD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Invasive Fungal Disease (IFD) Drugs Revenue
3.4 Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio
3.4.1 Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Invasive Fungal Disease (IFD) Drugs Revenue in 2023
3.5 Global Key Players of Invasive Fungal Disease (IFD) Drugs Head office and Area Served
3.6 Global Key Players of Invasive Fungal Disease (IFD) Drugs, Product and Application
3.7 Global Key Players of Invasive Fungal Disease (IFD) Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Invasive Fungal Disease (IFD) Drugs Breakdown Data by Type
4.1 Global Invasive Fungal Disease (IFD) Drugs Historic Market Size by Type (2019-2024)
4.2 Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Type (2025-2030)
5 Invasive Fungal Disease (IFD) Drugs Breakdown Data by Application
5.1 Global Invasive Fungal Disease (IFD) Drugs Historic Market Size by Application (2019-2024)
5.2 Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Invasive Fungal Disease (IFD) Drugs Market Size (2019-2030)
6.2 North America Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2019-2024)
6.4 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Invasive Fungal Disease (IFD) Drugs Market Size (2019-2030)
7.2 Europe Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2019-2024)
7.4 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size (2019-2030)
8.2 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Invasive Fungal Disease (IFD) Drugs Market Size (2019-2030)
9.2 Latin America Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2019-2024)
9.4 Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size (2019-2030)
10.2 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Invasive Fungal Disease (IFD) Drugs Introduction
11.1.4 Pfizer Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Invasive Fungal Disease (IFD) Drugs Introduction
11.2.4 Merck Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Introduction
11.3.4 Gilead Sciences Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Xellia
11.4.1 Xellia Company Details
11.4.2 Xellia Business Overview
11.4.3 Xellia Invasive Fungal Disease (IFD) Drugs Introduction
11.4.4 Xellia Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.4.5 Xellia Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Invasive Fungal Disease (IFD) Drugs Introduction
11.5.4 Lupin Limited Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.5.5 Lupin Limited Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Invasive Fungal Disease (IFD) Drugs Introduction
11.6.4 Abbott Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Creogenic Pharma
11.7.1 Creogenic Pharma Company Details
11.7.2 Creogenic Pharma Business Overview
11.7.3 Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Introduction
11.7.4 Creogenic Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.7.5 Creogenic Pharma Recent Development
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Company Details
11.8.2 Taj Pharmaceuticals Business Overview
11.8.3 Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Introduction
11.8.4 Taj Pharmaceuticals Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.8.5 Taj Pharmaceuticals Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Invasive Fungal Disease (IFD) Drugs Introduction
11.9.4 Astellas Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.9.5 Astellas Pharma Recent Development
11.10 Jiangsu Aosaikang Pharmaceutical
11.10.1 Jiangsu Aosaikang Pharmaceutical Company Details
11.10.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.10.3 Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Introduction
11.10.4 Jiangsu Aosaikang Pharmaceutical Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
11.10.5 Jiangsu Aosaikang Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Medicine
Table 3. Key Players of Injectable Medicine
Table 4. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Invasive Fungal Disease (IFD) Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region (2019-2024)
Table 8. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region (2025-2030)
Table 10. Invasive Fungal Disease (IFD) Drugs Market Trends
Table 11. Invasive Fungal Disease (IFD) Drugs Market Drivers
Table 12. Invasive Fungal Disease (IFD) Drugs Market Challenges
Table 13. Invasive Fungal Disease (IFD) Drugs Market Restraints
Table 14. Global Invasive Fungal Disease (IFD) Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Invasive Fungal Disease (IFD) Drugs Market Share by Players (2019-2024)
Table 16. Global Top Invasive Fungal Disease (IFD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Disease (IFD) Drugs as of 2023)
Table 17. Ranking of Global Top Invasive Fungal Disease (IFD) Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Invasive Fungal Disease (IFD) Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Headquarters and Area Served
Table 20. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Product and Application
Table 21. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Invasive Fungal Disease (IFD) Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Invasive Fungal Disease (IFD) Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Invasive Fungal Disease (IFD) Drugs Product
Table 49. Pfizer Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Invasive Fungal Disease (IFD) Drugs Product
Table 54. Merck Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Invasive Fungal Disease (IFD) Drugs Product
Table 59. Gilead Sciences Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Xellia Company Details
Table 62. Xellia Business Overview
Table 63. Xellia Invasive Fungal Disease (IFD) Drugs Product
Table 64. Xellia Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 65. Xellia Recent Development
Table 66. Lupin Limited Company Details
Table 67. Lupin Limited Business Overview
Table 68. Lupin Limited Invasive Fungal Disease (IFD) Drugs Product
Table 69. Lupin Limited Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 70. Lupin Limited Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Invasive Fungal Disease (IFD) Drugs Product
Table 74. Abbott Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Creogenic Pharma Company Details
Table 77. Creogenic Pharma Business Overview
Table 78. Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Product
Table 79. Creogenic Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 80. Creogenic Pharma Recent Development
Table 81. Taj Pharmaceuticals Company Details
Table 82. Taj Pharmaceuticals Business Overview
Table 83. Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Product
Table 84. Taj Pharmaceuticals Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 85. Taj Pharmaceuticals Recent Development
Table 86. Astellas Pharma Company Details
Table 87. Astellas Pharma Business Overview
Table 88. Astellas Pharma Invasive Fungal Disease (IFD) Drugs Product
Table 89. Astellas Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 90. Astellas Pharma Recent Development
Table 91. Jiangsu Aosaikang Pharmaceutical Company Details
Table 92. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 93. Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Product
Table 94. Jiangsu Aosaikang Pharmaceutical Revenue in Invasive Fungal Disease (IFD) Drugs Business (2019-2024) & (US$ Million)
Table 95. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Invasive Fungal Disease (IFD) Drugs Picture
Figure 2. Global Invasive Fungal Disease (IFD) Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Invasive Fungal Disease (IFD) Drugs Market Share by Type: 2023 VS 2030
Figure 4. Oral Medicine Features
Figure 5. Injectable Medicine Features
Figure 6. Global Invasive Fungal Disease (IFD) Drugs Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Invasive Fungal Disease (IFD) Drugs Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Drugstore Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Invasive Fungal Disease (IFD) Drugs Report Years Considered
Figure 13. Global Invasive Fungal Disease (IFD) Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Invasive Fungal Disease (IFD) Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Invasive Fungal Disease (IFD) Drugs Market Share by Players in 2023
Figure 17. Global Top Invasive Fungal Disease (IFD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Disease (IFD) Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Invasive Fungal Disease (IFD) Drugs Revenue in 2023
Figure 19. North America Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Invasive Fungal Disease (IFD) Drugs Market Share by Country (2019-2030)
Figure 21. United States Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Invasive Fungal Disease (IFD) Drugs Market Share by Country (2019-2030)
Figure 25. Germany Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Share by Region (2019-2030)
Figure 33. China Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Invasive Fungal Disease (IFD) Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 49. Merck Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 50. Gilead Sciences Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 51. Xellia Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 52. Lupin Limited Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 53. Abbott Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 54. Creogenic Pharma Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 55. Taj Pharmaceuticals Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 56. Astellas Pharma Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 57. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
